Article info
PDFFindings that shed new light on the possible pathogenesis of a disease or an adverse effect
CASE REPORT
Case of drug-induced interstitial lung disease secondary to adalimumab
- Correspondence to Dr Seema Alaee, seema.alaee{at}nhs.net
Citation
Case of drug-induced interstitial lung disease secondary to adalimumab
Publication history
- Accepted March 30, 2018
- First published May 15, 2018.
Online issue publication
August 07, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.